Amblyopia Clinical Trials 2023

Amblyopia Clinical Trials 2023

Amblyopia research studies recruiting patients in 2023 need your help. Receive premium care & cutting edge treatments by enrolling in amblyopia clinical trials today.

Amblyopia Clinical Trials

Here are the 5 most popular medical studies for amblyopia

Popular filter options for amblyopia trials

Lazy Eye Clinical Trials

View 11 Lazy Eye medical studies.

Amblyopia Clinical Trials With No Placebo

View 12 amblyopia medical studies that do not have a placebo group.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to amblyopia

What are the top hospitals conducting amblyopia research?

When it comes to cutting-edge clinical trials focused on amblyopia, several hospitals stand out for their commitment to advancing our understanding and treatment of this condition. In Dallas, the Retina Foundation of the Southwest leads the way with three active amblyopia trials and a total of five such trials in its history. Since conducting its first trial in 2010, this hospital has been dedicated to finding innovative solutions for amblyopia patients. Meanwhile, The Ohio State University College of Optometry in Columbus is making significant contributions as well. With two ongoing amblyopia trials and a total of three previously conducted studies since their inaugural trial in 2017, they are actively engaged in helping individuals affected by this visual disorder.

Additionally adding itself to this list is another facility from Dallas called Retina Foundation which not only partakes with two current investigations but also boasts commendable completion rate through prior two experiments ever recorded since initiating it's pioneering investigation on cases dealing with Amblyopia; their contribution can be traced back only few years ago commencing after2023.The Texas Children's Hospital located in Houston has also made noteworthy progress. With two active amblyopia trials alongside an equal number successfully completed since conducting their first study backin2001; they have emerged as an influential institution withinthis field. Lastly,SUNY CollegeofOptometrylocatedinNewYork joins these esteemed medical centerswith one ongoingclinicaltrial focusingonamblyopiawhilehaving accomplishedan additionalpreviousinvestigation sincerecordingtheirfirsttrial again starting from year 2023

These leading hospitals demonstrate a collective dedication towards improving outcomes for those affected by am

Which are the best cities for amblyopia clinical trials?

When it comes to amblyopia clinical trials, several cities are at the forefront of research and innovation. Dallas, Texas takes the lead with 5 active trials exploring treatments such as patch-free occlusion therapy and binocular games for amblyopia. Philadelphia, Pennsylvania follows closely behind with 4 ongoing studies focusing on glasses, treatment options, and OkuStim®. Columbus, Ohio boasts 3 active trials that investigate therapeutic virtual reality games alongside continued optical correction. New york City and Boston each have 3 active trials studying various aspects of amblyopia treatment including patching groups and glasses interventions. These cities offer individuals with amblyopia opportunities to participate in cutting-edge clinical trials that aim to improve vision outcomes and quality of life for affected individuals.

Which are the top treatments for amblyopia being explored in clinical trials?

Amblyopia, also known as lazy eye, is a condition that researchers are actively exploring in clinical trials. The top treatments being investigated include:

  • Patching group: Currently involved in one active trial and has been the subject of one all-time amblyopia trial since its introduction in 2017.

  • Perceptual Learning: Another treatment option being tested in one active trial and has shown promise with one all-time amblyopia trial since it was first listed in 2022.

  • Patch-free occlusion therapy: This innovative approach to treating amblyopia is currently undergoing testing in one active trial and has garnered attention with its inclusion in one all-time amblyopia trial since its listing began in 2023.

  • Glasses: A traditional yet effective treatment method for amblyopia, glasses are currently being examined through ongoing research efforts involving one active trial. They have also been the focus of one all-time amblyopia study after their initial listing back in 2020.

As these trials progress, there is hope for improved outcomes and new avenues for managing this vision disorder.

What are the most recent clinical trials for amblyopia?

Recent clinical trials offer hope for individuals with amblyopia, commonly known as lazy eye. These trials focus on innovative treatments aimed at improving vision and quality of life for patients. One such study explores the efficacy of occlusion therapy combined with virtual reality to enhance visual outcomes in children with amblyopia. Another trial investigates the potential benefits of binocular iPad games as a form of treatment to stimulate both eyes simultaneously. These groundbreaking studies represent exciting advancements in the field and bring us closer to finding effective interventions for amblyopia.

What amblyopia clinical trials were recently completed?

Recently completed clinical trials have made significant progress in the field of amblyopia, also known as "lazy eye." These trials focused on exploring innovative treatment options for this visual disorder. However, specific details about these recently completed trials were not provided. Further information is needed to determine the latest advancements and outcomes in amblyopia research.